A New Era in Obesity Treatment: GLP-1 Receptor Agonists and Future Health Management
Published
In recent years, a new type of medication called "GLP-1 receptor agonists" has been attracting global attention. Originally used to treat diabetes, these drugs have been found to have significant weight-loss effects, bringing about major changes in the field of obesity treatment. Interest in these medications is also growing in Japan, where their use in clinical settings is currently being debated.
American company Ilant Health is focusing not only on weight loss itself but also on maintaining health after weight has been lost. Many people feel reassured once they lose weight through medication, but there are risks such as loss of muscle mass and the potential for rebounding. The company provides programs that combine medication with proper diet and exercise to build a healthy body in the long term.
Within Japan, obesity remains a major issue as a cause of lifestyle-related diseases. According to a survey by the Ministry of Health, Labour and Welfare, the percentage of people suffering from obesity is increasing year by year, and effective measures are necessary to extend healthy life expectancy. While GLP-1 receptor agonists are promising, caution is required, as using them without a doctor's guidance carries the risk of side effects.
Moving forward, it is important not to rely solely on medication, but to improve lifestyle habits with the support of professionals. As new treatment methods become more widespread, a future where more people can live healthier lives is anticipated. With the evolution of medical technology, we are each being challenged to consider how we approach our own health.
Sources: Yahoo!ニュース
More Japan news
- Toyota, Nissan and Honda to Hold Engineer Event in Fiscal 2026 Under the Theme of “AI”
- HTC NIPPON Promotes Business Use of the Smart Glasses "VIVE Eagle" as Sponsor of Remote Guidance App Exhibition
- Defense-Related ETF "GX Defense Tech" Publishes Stock Price Information; Detailed News Not Available
- U.S. Ambassador to South Korea Marks 100 Days in Office, Stresses the Importance of Protecting Trust Between South Korea and the United States
- South Korean National Assembly Passes Special Counsel Act to Investigate "Fabricated Indictments"
- Former Professor Embroiled in Stem Cell Paper Fabrication Scandal Acquires UAE Citizenship, Loses South Korean Nationality
- Foreign Minister Motegi Holds Talks with Foreign Ministers of France, Italy and the UK, Calls for Appropriate Response on EU Exclusion of Japanese-Made EVs from Preferential Treatment
- Health Drink Market in Japan Set to Grow, Driven by Aging Population and Health Consciousness